tiprankstipranks
Trending News
More News >
Medley, Inc. (JP:4480)
:4480

Medley (4480) AI Stock Analysis

Compare
2 Followers

Top Page

JP

Medley

(Munich:4480)

Rating:68Neutral
Price Target:
¥3,543.00
▲(18.10%Upside)
Medley, Inc. demonstrates strong financial performance with robust revenue and profit growth and a solid balance sheet, which is the primary driver of the score. Technical analysis shows mixed signals, reflecting some uncertainty in stock momentum. Valuation appears high, suggesting limited immediate upside. Overall, while the company's fundamentals are strong, valuation concerns and mixed technical indicators warrant a cautious approach.

Medley (4480) vs. iShares MSCI Japan ETF (EWJ)

Medley Business Overview & Revenue Model

Company DescriptionMedley, Inc. is a healthcare technology company based in Japan, focusing on the development and operation of online platforms and services within the medical and healthcare sectors. The company operates various online services such as job placement for medical professionals, telemedicine services, and healthcare media content aimed at improving access to medical information and resources.
How the Company Makes MoneyMedley, Inc. generates revenue through multiple streams, primarily from its online platforms and services. The company earns income by charging fees for job placement and recruitment services within the healthcare sector, facilitating connections between medical professionals and healthcare institutions. Additionally, Medley offers telemedicine services, generating revenue through subscription models and service fees from healthcare providers and patients. The company also monetizes its healthcare media content through advertising and partnerships with pharmaceutical and healthcare companies seeking to reach a targeted audience.

Medley Financial Statement Overview

Summary
Overall, Medley, Inc. is in a strong financial position. The company shows impressive revenue and profit growth, along with stable cash flow generation. The balance sheet reflects a strong equity position and manageable debt levels. While there are some areas to monitor, such as operational efficiency and investment returns, the financial health of the company is positive and supports continued growth.
Income Statement
88
Very Positive
Medley, Inc. has demonstrated strong revenue growth, with a significant increase from 2023 to 2024, indicating a positive growth trajectory. The gross profit margin remains robust, and the net profit margin is healthy, reflecting efficient cost management. However, the slight decline in EBIT margin suggests potential pressure on operational efficiency.
Balance Sheet
82
Very Positive
The company's balance sheet is stable, with a solid equity base and a healthy debt-to-equity ratio, indicating low financial leverage. The equity ratio is also strong, reflecting a well-capitalized structure. However, the increase in total liabilities warrants monitoring, as it could impact future financial flexibility.
Cash Flow
85
Very Positive
Medley, Inc. exhibits strong cash flow generation, with positive free cash flow and a favorable operating cash flow to net income ratio. The free cash flow growth rate is commendable, suggesting efficient capital expenditure management. Despite this, the significant negative investing cash flow highlights substantial investments, which could pose risks if not yielding expected returns.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
29.30B20.53B14.19B10.86B6.83B
Gross Profit
18.92B13.36B9.72B6.99B4.67B
EBIT
2.33B2.66B1.29B733.25M396.09M
EBITDA
4.00B4.50B2.14B1.25B586.57M
Net Income Common Stockholders
2.80B2.57B1.02B563.00M455.99M
Balance SheetCash, Cash Equivalents and Short-Term Investments
19.00B15.35B14.42B14.29B14.05B
Total Assets
45.20B25.43B21.81B20.21B15.52B
Total Debt
15.18B1.66B2.38B3.11B4.18B
Net Debt
-3.81B-13.69B-12.05B-11.19B-9.87B
Total Liabilities
24.98B7.79B6.64B6.16B5.80B
Stockholders Equity
20.21B17.55B15.08B13.97B9.72B
Cash FlowFree Cash Flow
2.38B3.47B1.64B796.39M591.87M
Operating Cash Flow
2.45B3.87B2.01B1.04B805.76M
Investing Cash Flow
-10.72B-1.66B-751.00M-3.29B-283.15M
Financing Cash Flow
11.90B-1.22B-927.00M2.22B9.05B

Medley Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3000.00
Price Trends
50DMA
3191.42
Negative
100DMA
3306.54
Negative
200DMA
3539.70
Negative
Market Momentum
MACD
-92.09
Positive
RSI
36.37
Neutral
STOCH
35.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4480, the sentiment is Negative. The current price of 3000 is below the 20-day moving average (MA) of 3142.55, below the 50-day MA of 3191.42, and below the 200-day MA of 3539.70, indicating a bearish trend. The MACD of -92.09 indicates Positive momentum. The RSI at 36.37 is Neutral, neither overbought nor oversold. The STOCH value of 35.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4480.

Medley Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥124.95B20.11
2.00%12.93%-14.89%
68
Neutral
¥97.22B43.1712.05%42.90%-16.04%
68
Neutral
¥237.31B32.61
0.44%28.85%54.60%
65
Neutral
¥19.58B19.99
1.57%17.20%20.25%
54
Neutral
$5.31B3.26-45.10%2.79%16.76%0.02%
45
Neutral
¥9.63B
-79.38%-1239.83%
43
Neutral
¥15.64B4,465.71
1.62%-7.98%-181.00%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4480
Medley
3,000.00
-540.00
-15.25%
JP:2175
SMS Co., Ltd.
1,419.00
-475.48
-25.10%
JP:3902
Medical Data Vision Co.Ltd.
401.00
-105.17
-20.78%
JP:3939
Kanamic Network Co., LTD.
415.00
-123.50
-22.93%
JP:4263
SUSMED,Inc.
583.00
11.00
1.92%
JP:4483
JMDC Inc.
3,694.00
529.49
16.73%

Medley Corporate Events

Medley, Inc. Announces Change in Major Shareholder
May 26, 2025

Medley, Inc. announced a change in its major shareholder, with OLP Capital Management Limited reducing its shareholding from 10.83% to 9.57%. This change in shareholding is based on a large-volume shareholding report, and the company states that it does not foresee any significant impact on its operations or outlook.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen7400.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

Medley, Inc. Completes Treasury Share Disposal
Apr 11, 2025

Medley, Inc. has completed the disposal of treasury shares as restricted stock compensation to its employees and subsidiaries, following a resolution made by the Board of Directors. The number of shares disposed was slightly adjusted due to the forfeiture of rights by one potential allottee, but this change does not impact the company’s financial forecast for the fiscal year ending December 2025.

Medley, Inc. Enhances Corporate Governance and Promotes Diversity
Mar 26, 2025

Medley, Inc. is committed to strengthening its corporate governance by enhancing the supervisory function of its Board of Directors and improving information disclosure. The company is also focused on promoting diversity and ensuring fair hiring practices, while considering the potential for strategic shareholdings to foster long-term growth. Although climate change is not expected to impact its business significantly, Medley is taking steps to address it through energy conservation and digitization initiatives.

Medley, Inc. Aligns Leadership Incentives with Shareholder Interests
Mar 25, 2025

Medley, Inc. announced the disposal of 89,200 treasury shares as restricted stock compensation to its directors and executive officers. This move is part of a broader plan to align the interests of the company’s leadership with its shareholders by tying compensation to the company’s share price. The initiative is designed to incentivize the sustainable increase of corporate value, with varying transfer restriction periods to encourage long-term commitment.

Medley, Inc. Announces Strategic Share Repurchase Plan
Mar 10, 2025

Medley, Inc. announced a resolution to repurchase up to 350,000 of its common shares, representing 1.1% of its total issued shares, with an aggregate amount of up to 1,000 million yen. This strategic move, set to occur between March 11 and September 30, 2025, aims to provide flexibility in response to share price fluctuations and to return profits to shareholders, potentially impacting the company’s market positioning and shareholder value.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.